INTRODUCTION
============

Vertebroplasty or kyphoplasty is commonly used for the treatment of osteoporotic vertebral fracture (OVF)[@b6-jkns-60-2-181],[@b17-jkns-60-2-181],[@b18-jkns-60-2-181]. However, it was reported that there was either a similar or no beneficial effect of vertebroplasty in OVF compared to a control group in two prospective randomized multicenter trials in 2009[@b1-jkns-60-2-181],[@b7-jkns-60-2-181]. However, many studies still report a superior effect of vertebroplasty in OVF, and thus there is still some debate about the therapeutic effect of vertebroplasty or kyphoplasty in OVF.

The most common complication of a conservative therapy in OVF is vertebral collapse caused by further compression over time[@b2-jkns-60-2-181]. Particularly, OVF often develops in the thoracolumbar junction, in which stress-loading is greatest, and wedge-shaped fracture types primarily occur[@b3-jkns-60-2-181]. Thus, vertebral collapse induces progressive kyphosis and consequently persistent back pain and neurological deficiency.

We measured necrotic and edematous area using highly reliable and sensitive contrast-enhanced magnetic resonance imaging (CEMRI) in OVF and examined the strength of the correlation by comparing with compression after 6 months. Additionally, comparative analysis was performed to determine how the range of the necrotic area affected not only radiological outcome but also clinical outcome.

MATERIALS AND METHODS
=====================

Subjects
--------

Eighty-seven patients admitted for OVF from January 2012 to December 2014 were retrospectively recruited as study subjects. The OVF patients engaged in this study were patients aged 50 and older who had single-level vertebral fracture without posterior ligament injury among AO classification A1--3 and compression or burst fracture without neurological deficiency; all subjects also had adequate pain relief with a score of 1--2 points in the thoracolumbar injury classification and severity score[@b15-jkns-60-2-181],[@b16-jkns-60-2-181]. Adequate pain relief was based on a visual analog scale (VAS) (0--10) score maintained below 5 points with an active medical therapy (opioid medication and pain block). During this period, vertebroplasty or kyphoplasty was performed in five patients (5.7%). Of these, five patients were AO classification A3 and complained of intolerable pain for 1 month or longer. This study was conducted without external funding.

Compression
-----------

Further compression was measured by means of lateral plain radiography. The ratio (%) of reduced vertebral body area was measured at 1 month and 6 months based on the vertebral body area of fracture on lateral plain radiography at admission. Additionally, the edematous and necrotic areas of the fracture lesion in a middle sagittal section were measured using CEMRI, and the fracture areas examined on CEMRI at admission were defined as edematous if enhancement was seen and as necrotic if no enhancement was seen using picture archiving and communication system (Maroview version 5.4, Marotech Inc., Seoul, Korea). The areas of necrosis, edema, and necrosis+edema were obtained as a ratio (%) based on the entire area of the fractured vertebral body ([Fig. 1A](#f1-jkns-60-2-181){ref-type="fig"})[@b12-jkns-60-2-181]. Then, correlations of further compression were studied with respect to the necrotic and edematous areas seen on CEMRI, age, and bone mineral density (BMD), which were believed to be closely correlated with further compression.

Based on this, comparative analysis of the clinical and radiological outcome of each group was performed by dividing the groups into those with necrotic areas of less than 25% (non-necrosis group) or more than 25% group (necrosis group) based on the size of the necrotic area on CEMRI.

Outcome measures
----------------

For clinical outcomes, VAS and Eastern Cooperative Oncology Group (ECOG) performance status were used at 1 month, 3 months, and 6 months after admission to verify the severity and duration of pain[@b11-jkns-60-2-181]. In accordance with the ECOG performance status grade, grade 0 indicates fully active, able to carry on all pre-disease performance without restriction; grade 1 indicates symptomatic but fully ambulatory; Grade 2 indicates symptomatic and up and about for more than 50% of waking hours; and Grade 3 indicates symptomatic and confined to bed or a chair for 50% of waking hours.

The development of the intervertebral cleft was defined as cases in which intervertebral air or fluid was observed or change in anterior vertebral height of ≥3 mm was observed on flexion/extension lateral plain radiography.

Anterior, middle, and posterior height were measured on lateral plain radiography at admission and at 1 week, 1 month, and 6 months after admission; the Cobb angle comprised of the upper endplate and the lower endplate of the fractured vertebral body was defined as the wedge angle, and the Cobb angle comprised of the upper endplate of the upper vertebral body and the lower endplate of the lower vertebral body of a fractured vertebral body was defined as the segmental angle ([Fig. 1B](#f1-jkns-60-2-181){ref-type="fig"}).

Statistical analysis
--------------------

The Pearson method was used to determine the correlation between further compression and necrosis and edema, BMD, and age on contrast-enhanced MRI. Variables between the non-necrosis and necrosis groups were compared using an independent t-test, Mann-Whitney's U test, and chi-squared test. *p*\<0.05 was considered statistically significant. Statistical analyses were performed using SPSS software version 18.0 (SPSS Inc., Chicago, IL, USA).

RESULTS
=======

The study was performed in a total of 82 patients from January 2012 to December 2014, the mean age of subjects was 69.27±10.33 years, and the ratio of men to women was 18 to 64, indicating a greater number of women. Distribution was mainly in T12, L1, and L2. When the entire fractured area on plain radiography examined at admission was set as a baseline, the development of further compression was 14.78±11.11% at 1 month post-injury and 21.75±14.43% at 6 months post-injury. Moreover, on the CEMRI, the necrotic area accounted for 21.71±16.27%, the edematous area accounted for 47.93±16.54%, and the fractured area accounted for 69.64±19.12% ([Table 1](#t1-jkns-60-2-181){ref-type="table"}). According to this, the correlation between the degree of further compression at 6 months post-injury and age, BMD, necrotic area, and edematous area was obtained. There was no correlation between further compression and age and BMD, but there was a positive correlation between further compression and necrotic area (Pearson's correlation coefficient=0.690, *p*\<0.001; [Fig. 2](#f2-jkns-60-2-181){ref-type="fig"}). The further compression that developed at 6 months post-injury was almost identical to the necrotic area on contrast-enhanced MRI.

Comparative analysis was performed by dividing the subjects into non-necrosis and necrosis groups based on the size of the necrotic area on CEMRI. There was no difference between the two groups in terms of age, sex, hypertension, diabetes mellitus, BMD, vertebral shape, and osteoporotic medication. However, when compression was measured at 1 month and 6 months, it was 10.35±7.09 and 14.96±10.34% in the non-necrosis group, respectively, but was statistically significantly higher 22.46±12.64 and 33.52±12.96% at the necrosis group, respectively ([Fig. 3](#f3-jkns-60-2-181){ref-type="fig"}). Moreover, the development of intervertebral cleft (n=13, 43.3%) in the necrosis group was higher than that (n=6, 11.5%) in the non-necrosis group; furthermore, three patients in the necrosis group needed surgical treatment due to neurologic deficiency. The necrosis group had a statistically significantly poorer clinical outcome in comparison to the non-necrosis group based on VAS at 1 month, 3 months, and 6 months post-injury. Moreover, ECOG performance status showed similar results ([Table 2](#t2-jkns-60-2-181){ref-type="table"}).

In regards to radiologic outcome, vertebral height and wedge and segmental angles at 1 week, 1 month, and 6 months after injury were compared. As a result, statistical differences in anterior vertebral height were seen starting from 1 week after injury. In addition, over time, there was a difference between the two groups in middle and posterior vertebral height. Moreover, wedge and segmental angles showed a difference at 6 months post-injury, and the difference between the two groups increased for both wedge and segmental angle over time ([Table 3](#t3-jkns-60-2-181){ref-type="table"}).

DISCUSSION
==========

Vertebral collapse often occurs unpredictably in OVF and develops as a consequence of a vascular insult in the anterior segment of the vertebral body supplied by the anterior metaphyseal and peripheral arteries. This induces inadequate revascularization in bone marrow and impairs the fracture healing process, thus it induces failure of the reparative process and promotes avascular necrosis of the vertebral body. Consequently, vertebral collapse develops progressively[@b12-jkns-60-2-181],[@b14-jkns-60-2-181]. The current result also shows that the incidence of further compression was 14.8% at 1 month and 21.8% at 6 months when conservative therapy was attempted in OVF.

CEMRI is a highly reliable and sensitive test that can accurately verify the range of avascular necrosis in OVF patients [@b12-jkns-60-2-181]. Moreover, the enhancing pattern of a fractured vertebra on CEMRI is useful to assess blood supply in bone contusions. Additionally, the ischemic necrotic area on CEMRI can be used to predict the pattern and amount of injected bone cement when percutaneous vertebroplasty was performed[@b11-jkns-60-2-181]. The present study also showed further compression developed in proportion to the necrotic portion on CEMRI in OVF. This indicates that the degree of further compression is readily predictable through CEMRI, and thus it would be helpful for selecting patients requiring vertebroplasty, kyphoplasty, or surgery.

Comparisons between the two groups were made based on the range of necrosis. Consequently, the incidence of intervertebral cleft and cases requiring a surgical procedure were greater in the necrosis group. Accordingly, it was demonstrated that intervertebral cleft occurred more frequently in cases with a large range of necrosis. Intervertebral cleft increases mobility and induces more pain per se[@b6-jkns-60-2-181],[@b8-jkns-60-2-181],[@b9-jkns-60-2-181]. Likewise, it has been reported that the incidence of cement leakage is high when vertebroplasty is performed in cases of intervertebral cleft, and the benefit of vertebroplasty is a delayed and decreased effect[@b4-jkns-60-2-181],[@b8-jkns-60-2-181]. Because cement is injected in a clump-like pattern in a condition with intervertebral cleft rather than in a sponge-like pattern in a condition without intervertebral cleft when vertebroplasty was performed, the interdigitation of bone and cement becomes weakened. Thus, interlocking bone is weakened, the stabilizing effect of cement is reduced, and consequently the pain reduction effect is small[@b10-jkns-60-2-181]. Furthermore, a surgical procedure can be necessary as nonunion develops. In our results, the incidence of intervertebral cleft was 43.3% in the necrosis group. In addition, the possibility of intervertebral cleft development is high if the necrotic range is large on CEMRI. his may serve as a sufficiently useful indicator to select patients who might benefit from active treatment after assessment of the necrotic range.

The kyphotic change in OVF aggravates physical function and quality of life[@b13-jkns-60-2-181]. Vertebral kyphotic deformity also increases mortality and adjacent fracture incidence[@b5-jkns-60-2-181]. The radiological outcome in our results showed a difference between the two groups. OVF develops most commonly in wedge-shaped fractures, and the necrotic portion is mainly located anteriorly, and thus the vertebral height decreases from the anterior vertebral height in order. Furthermore, it was found that the wedge and kyphotic angles worsened in the group whose necrosis advanced over time. This was a major cause of constant back pain and affected performance status.

This study has some limitations. This study used retrospective data at a single medical center. To overcome this limitation, medical treatment and pain block was actively performed, and vertebroplasty or kyphoplasty was performed in only 5.7% of OVF patients. In addition, plain radiography was consistently measured, and the progress was observed to 6 months, which is sufficient to determine if neurologic deficiency had developed. However, the short-term 6-month follow-up is a limitation. Accordingly, a long-term multicenter prospective study is needed in further studies.

CONCLUSION
==========

There is a strong correlation between the necrotic area on CEMRI and the development of further compression in OVF. Additionally, with a large degree of necrosis, intervertebral cleft develops, and kyphotic change is induced with poor clinical outcome. Therefore, identifying necrotic areas by performing CEMIRI on OVF patients would be helpful in determining their prognosis and treatment course.

![A: Contrast-enhanced magnetic resonance image shows necrotic (a) and edematous (b) areas. B: Radiography shows the segmental angle (c), wedge angle (d), anterior height (e), middle height (f), and posterior height (g) in osteoporotic vertebral fracture.](jkns-60-2-181f1){#f1-jkns-60-2-181}

![Correlations of further compression at 6 months and factors affecting further compression. The x axes indicate further compression at 6 months. The y axes indicate (A) necrotic area (%) on contrast-enhanced MRI, (B) edema area (%) on contrast-enhanced MRI, (C) age, and (D) BMD. Further compression at 6 months and necrotic area (%) shows the strongest correlation. MRI: magnetic resonance imaging, BMD: bone mineral density, r: correlation coefficient.](jkns-60-2-181f2){#f2-jkns-60-2-181}

![A 76-year-old man with a benign osteoporotic vertebral fracture of the first lumbar vertebra. On (A) T2-, (B) T1-, and (C) fat-suppressed T2-weighted MRI, the signal of the vertebral body appears as isointensity and low and high signal intensity rather than as signal void. On (D) contrast-enhanced MRI, an area (arrow) with low signal intensity (necrotic area) is clearly shown within a diffusely enhanced area (edematous area). (E--G), and (H) on plain lateral radiography, there was a gradual reduction of disc height, and the conversion of wedge and segmental angles into a kyphotic change was found over time. MRI: magnetic resonance imaging.](jkns-60-2-181f3){#f3-jkns-60-2-181}

###### 

Patient demographic data

  Variable                                  Value
  ----------------------------------------- -------------
  Age                                       69.27±10.33
                                            
  Sex (M: F)                                18: 64
                                            
  Hypertension                              38
                                            
  DM                                        16
                                            
  Smoking                                   9
                                            
  Level                                     
   T11                                      2
   T12                                      19
   L1                                       31
   L2                                       26
   L3                                       4
                                            
  Vertebral shape                           
   Wedge                                    51
   Biconcave                                17
   Crush                                    14
                                            
  BMD                                       −2.74±1.22
                                            
  Further compression rate at 1 month (%)   14.78±11.11
                                            
  Further compression rate at 6 month (%)   21.75±14.43
                                            
  Necrosis area (%)                         21.71±16.27
                                            
  Edema area (%)                            47.93±16.54
                                            
  Necrosis+Edema area (%)                   69.64±19.12
                                            
  Unhealed                                  19
                                            
  Surgery                                   3
                                            
  VAS (1 month)                             2.99±0.83
                                            
  VAS (3 months)                            2.37±1.18
                                            
  VAS (6 months)                            2.28±1.15
                                            
  ECOG performance scale (0/1/2/3)          42/28/10/2

Values are presented as mean±standard deviation or number. DM: diabetes mellitus, BMD: bone mineral density, VAS: visual analog scale, ECOG: Eastern Cooperative Oncology Group

###### 

Clinical data of patients

  Variable                                                                            Necrosis \<25% (n=52)   Necrosis \>25% (n=30)   *p*-value
  ----------------------------------------------------------------------------------- ----------------------- ----------------------- -----------
  Age (year)                                                                          68.69±11.97             70.27±6.76              0.45
                                                                                                                                      
  Sex (M: F)                                                                          11:41                   7:23                    1
                                                                                                                                      
  Hypertension                                                                        25                      13                      0.652
                                                                                                                                      
  DM                                                                                  11                      5                       0.775
                                                                                                                                      
  Smoking                                                                             6                       3                       1
                                                                                                                                      
  Level[\*](#tfn3-jkns-60-2-181){ref-type="table-fn"}                                                                                 0.008
   T11                                                                                1                       1                       
   T12                                                                                7                       12                      
   L1                                                                                 21                      10                      
   L2                                                                                 22                      4                       
   L3                                                                                 1                       3                       
                                                                                                                                      
  Vertebral shape                                                                                                                     0.221
   Wedge                                                                              36                      15                      
   Biconcave                                                                          9                       8                       
   Crush                                                                              7                       7                       
                                                                                                                                      
  Osteoporotic medication                                                                                                             0.765
   Bisphosphonate                                                                     24                      15                      
   Teriparatide                                                                       12                      8                       
                                                                                                                                      
  BMD                                                                                 −2.69±1.31              −2.87±1.05              0.625
                                                                                                                                      
  Further compression at 1 month (%)[\*](#tfn3-jkns-60-2-181){ref-type="table-fn"}    10.35±7.09              22.46±12.64             \<0.001
                                                                                                                                      
  Further compression at 6 months (%)[\*](#tfn3-jkns-60-2-181){ref-type="table-fn"}   14.96±10.34             33.52±12.96             \<0.001
                                                                                                                                      
  Necrotic area (%)[\*](#tfn3-jkns-60-2-181){ref-type="table-fn"}                     11.95±7.35              38.62±13.33             \<0.001
                                                                                                                                      
  Edematous area (%)                                                                  50.23±17.94             43.59±13.22             0.098
                                                                                                                                      
  Necrotic+Edematous area (%)[\*](#tfn3-jkns-60-2-181){ref-type="table-fn"}           62.18±17.95             82.57±13.48             \<0.001
                                                                                                                                      
  Intervertebral cleft[\*](#tfn3-jkns-60-2-181){ref-type="table-fn"}                  6                       13                      0.002
                                                                                                                                      
  Surgery[\*](#tfn3-jkns-60-2-181){ref-type="table-fn"}                               0                       3                       0.046
                                                                                                                                      
  VAS (1 month)[\*](#tfn3-jkns-60-2-181){ref-type="table-fn"}                         2.74±0.83               3.77±1.01               \<0.001
                                                                                                                                      
  VAS (3 months)[\*](#tfn3-jkns-60-2-181){ref-type="table-fn"}                        1.87±0.91               3.23±1.10               \<0.001
                                                                                                                                      
  VAS (6 months)[\*](#tfn3-jkns-60-2-181){ref-type="table-fn"}                        1.79±0.82               3.13±1.14               \<0.001
                                                                                                                                      
  ECOG performance scale (0/1/2/3)[\*](#tfn3-jkns-60-2-181){ref-type="table-fn"}      33/16/3/0               9/12/7/2                0.001

Values are presented as mean±standard deviation or number.

Statistically significant difference.

DM: diabetes mellitus, BMD: bone mineral density, VAS: visual analog scale, ECOG: Eastern Cooperative Oncology Group

###### 

Radiologic changes over time

                                           Trauma day   1 week                                                1 month                                                 6 months
  ----------------------- ---------------- ------------ ----------------------------------------------------- ------------------------------------------------------- -------------------------------------------------------
  Anterior height (mm)    Necrosis \<25%   20.46±4.80   19.23±4.68                                            17.82±4.41                                              16.30±4.51
                          Necrosis \>25%   19.42±4.44   16.58±4.32                                            13.66±3.91                                              11.21±3.33
  *p*-value                                0.334        0.013[\*](#tfn6-jkns-60-2-181){ref-type="table-fn"}   \<0.001[\*](#tfn6-jkns-60-2-181){ref-type="table-fn"}   \<0.001[\*](#tfn6-jkns-60-2-181){ref-type="table-fn"}
  Middle height (mm)      Necrosis \<25%   17.22±4.36   15.46±4.67                                            14.85±3.97                                              13.06±4.05
                          Necrosis \>25%   16.18±3.76   13.94±3.42                                            11.99±3.19                                              10.19±3.15
  *p*-value                                0.277        0.124                                                 0.001[\*](#tfn6-jkns-60-2-181){ref-type="table-fn"}     0.001[\*](#tfn6-jkns-60-2-181){ref-type="table-fn"}
  Posterior height (mm)   Necrosis \<25%   27.65±4.98   26.67±4.68                                            25.98±5.87                                              25.47±4.96
                          Necrosis \>25%   26.04±4.10   24.94±3.41                                            24.26±3.97                                              22.18±4.63
  *p*-value                                0.137        0.081                                                 0.158                                                   0.004[\*](#tfn6-jkns-60-2-181){ref-type="table-fn"}
  Wedge angle (°)         Necrosis \<25%   11.68±6.48   13.57±5.86                                            15.51±6.69                                              15.90±6.71
                          Necrosis \>25%   10.87±5.79   14.22±6.03                                            18.05±5.18                                              19.30±7.48
  *p*-value                                0.572        0.637                                                 0.078                                                   0.037[\*](#tfn6-jkns-60-2-181){ref-type="table-fn"}
  Segmental angle (°)     Necrosis \<25%   9.96±8.77    10.63±9.80                                            12.37±9.97                                              14.06±9.86
                          Necrosis \>25%   8.93±6.99    12.22±8.09                                            15.70±8.95                                              18.85±9.75
  *p*-value                                0.587        0.452                                                 0.134                                                   0.037[\*](#tfn6-jkns-60-2-181){ref-type="table-fn"}

Values are presented as mean±standard deviation.

Statistically significant difference
